SHELL ASSET MANAGEMENT CO - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 364 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
SHELL ASSET MANAGEMENT CO ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q1 2024$1,065
+53.2%
42,562
+86.7%
0.02%
-25.0%
Q4 2023$695
-10.0%
22,801
-6.6%
0.03%0.0%
Q3 2023$772
-22.6%
24,421
-0.2%
0.03%
-17.9%
Q2 2023$998
+1484.1%
24,476
+1346.6%
0.04%
+1200.0%
Q1 2023$63
+6.8%
1,692
-0.4%
0.00%0.0%
Q4 2022$59
-99.9%
1,698
-16.8%
0.00%
-25.0%
Q3 2022$114,000
-14.3%
2,042
-20.7%
0.00%0.0%
Q2 2022$133,000
-28.9%
2,576
+0.2%
0.00%0.0%
Q1 2022$187,000
-46.4%
2,572
-12.9%
0.00%
-42.9%
Q4 2021$349,000
-11.4%
2,952
+0.6%
0.01%
-22.2%
Q3 2021$394,0002,9350.01%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Darwin Global Management, Ltd. 1,859,926$301,141,00048.58%
Burrage Capital Management LLC 63,634$10,303,00010.33%
Elmwood Wealth Management, Inc. 67,174$10,876,0005.73%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 300,327$48,626,0004.72%
Discovery Value Fund 929,669$150,523,0004.08%
Ikarian Capital, LLC 294,400$47,667,0003.85%
Ally Bridge Group (NY) LLC 93,127$15,078,0003.75%
GREAT POINT PARTNERS LLC 100,000$16,191,0003.40%
ARK Investment Management 7,684,441$1,244,188,0002.32%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$18,043,0002.30%
View complete list of INTELLIA THERAPEUTICS INC shareholders